We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $73.4B Turnover 30.34%
1-Year Est. Return 32.8%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+8.44%
1 Year Est. Return
+32.8%
3 Year Est. Return
+177.41%
5 Year Est. Return
+184.82%
10 Year Est. Return
+833.33%
AUM
$67.6B
AUM Growth
+$1.06B
Cap. Flow
-$786M
Cap. Flow %
-1.16%
Top 10 Hldgs %
10.48%
Holding
4,032
New
546
Increased
1,485
Reduced
1,480
Closed
497
Avg Time Held
3.2 years
Top 10 Avg Time Held
2.1 years
Top 20 Avg Time Held
2.1 years

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$191M
2
NKE icon
Nike
NKE
+$190M
3
UNH icon
UnitedHealth
UNH
+$158M
4
SHOP icon
Shopify
SHOP
+$153M
5
TSM icon
TSMC
TSM
+$151M

Top Sells

Rank Stock Value
1
PLTR icon
Palantir
PLTR
+$910M
2
MSFT icon
Microsoft
MSFT
+$668M
3
META icon
Meta Platforms (Facebook)
META
+$351M
4
MU icon
Micron Technology
MU
+$244M
5
AAPL icon
Apple
AAPL
+$191M

Sector Composition

Rank Sector Weight
1 Technology 20.84%
2 Healthcare 15.79%
3 Consumer Discretionary 14.08%
4 Industrials 9%
5 Financials 8.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PLTR icon
1
Palantir
PLTR
$386B
$1.72B 2.55%
22,789,809
-15,629,431
-41% -$910M
2021 Q2
14 quarters
UTHR icon
2
United Therapeutics
UTHR
$25B
$737M 1.09%
2,089,392
-66,000
-3% -$24.3M
2013 Q2
46 quarters
NVO icon
3
Novo Nordisk
NVO
$183B
$715M 1.06%
8,312,996
+123,681
+2% +$13.4M
2013 Q2
46 quarters
AAPL icon
4
Apple
AAPL
$5.13T
$618M 0.91%
2,467,613
-808,590
-25% -$191M
2020 Q3
17 quarters
VRSN icon
5
VeriSign
VRSN
$27.7B
$603M 0.89%
2,915,271
-260,719
-8% -$49.1M
2013 Q2
46 quarters
SFM icon
6
Sprouts Farmers Market
SFM
$4.63B
$567M 0.84%
4,464,644
+24,000
+0.5% +$3.19M
2016 Q2
34 quarters
VRTX icon
7
Vertex Pharmaceuticals
VRTX
$136B
$563M 0.83%
1,397,209
-234,284
-14% -$109M
2017 Q1
31 quarters
ABNB icon
8
Airbnb
ABNB
$109B
$549M 0.81%
4,175,351
+558,856
+15% +$75.3M
2021 Q2
14 quarters
EXEL icon
9
Exelixis
EXEL
$16.4B
$509M 0.75%
15,295,865
-64,051
-0.4% -$2.08M
2016 Q3
33 quarters
GILD icon
10
Gilead Sciences
GILD
$208B
$492M 0.73%
5,329,743
+1,141,219
+27% +$103M
2014 Q4
40 quarters
NVDA icon
11
NVIDIA
NVDA
$3.77T
$477M 0.71%
3,551,227
+23,156
+0.7% +$3.19M
2023 Q1
7 quarters
SPOT icon
12
Spotify
SPOT
$126B
$455M 0.67%
1,016,587
+336,581
+49% +$144M
2022 Q1
11 quarters
CCL icon
13
Carnival
CCL
$39B
$451M 0.67%
18,097,001
+2,720,096
+18% +$63.7M
2023 Q2
6 quarters
HOOD icon
14
Robinhood
HOOD
$64.9B
$450M 0.67%
12,078,116
+3,091,514
+34% +$100M
2022 Q3
9 quarters
RBLX icon
15
Roblox
RBLX
$33B
$438M 0.65%
7,570,959
+1,478,421
+24% +$74.4M
2021 Q2
14 quarters
FTNT icon
16
Fortinet
FTNT
$90.6B
$437M 0.65%
4,621,210
-321,952
-7% -$28.6M
2015 Q3
37 quarters
DASH icon
17
DoorDash
DASH
$74B
$415M 0.61%
2,473,488
+286,800
+13% +$47.1M
2021 Q2
14 quarters
DOCU icon
18
DocuSign
DOCU
$14.9B
$392M 0.58%
4,363,292
+205,304
+5% +$16.4M
2019 Q3
21 quarters
FNV icon
19
Franco-Nevada
FNV
$46.3B
$372M 0.55%
3,159,439
+20,890
+0.7% +$2.58M
2014 Q1
43 quarters
TEAM icon
20
Atlassian
TEAM
$37.8B
$367M 0.54%
1,508,523
-12,200
-0.8% -$2.79M
2016 Q2
34 quarters
NFLX icon
21
Netflix
NFLX
$249B
$364M 0.54%
4,079,350
-122,740
-3% -$10.1M
2024 Q2
2 quarters
CBOE icon
22
Cboe Global Markets
CBOE
$39.4B
$362M 0.54%
1,853,124
-26,600
-1% -$5.48M
2013 Q2
46 quarters
ZM icon
23
Zoom
ZM
$28.1B
$351M 0.52%
4,304,848
+380,900
+10% +$29.9M
2020 Q1
19 quarters
ALSN icon
24
Allison Transmission
ALSN
$10.4B
$346M 0.51%
3,200,824
-222,595
-7% -$24.3M
2013 Q3
45 quarters
NBIX icon
25
Neurocrine Biosciences
NBIX
$16.7B
$340M 0.5%
2,489,397
-85,149
-3% -$10.5M
2018 Q4
24 quarters

Similar funds

Jim Simons's Q4 2024 Portfolio in Review

As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Jim Simons's Q4 2024 filing shows 546 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
  • Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
  • Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
  • Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
  • Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
  • Jim Simons opened 546 new positions and closed 497 in Q4 2024.
  • Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.

Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.